StonvexLoading…
StonvexStonvexStonvexCore line items from LXFR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $384.60M | $391.90M | $405.00M | $423.40M |
Operating Income | $24.00M | $30.10M | $4.20M | $44.80M |
Net Income | $7.70M | $18.40M | $-1.90M | $26.90M |
EPS (Diluted) | $0.28 | $0.68 | $-0.07 | $0.98 |
Total Assets | $369.70M | $382.40M | $372.10M | $407.10M |
Total Liabilities | $143.30M | $162.90M | $159.50M | $199.80M |
Cash & Equivalents | $8.30M | $4.10M | $2.30M | $12.60M |
Free Cash Flow OCF − CapEx | $26.20M | $40.80M | $16.90M | $7.60M |
Shares Outstanding | 26.64M | 26.74M | 26.83M | 27.54M |